
Biren Amin
Stock Analyst at Piper Sandler
(2.27)
# 3,201
Out of 5,134 analysts
675
Total ratings
41%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBIO Crescent Biopharma | Rated: Buy | $35 → $32 | $14.15 | +126.15% | 27 | Nov 13, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $20 | $16.07 | +24.46% | 31 | Nov 13, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $21 → $15 | $2.14 | +600.93% | 12 | Nov 11, 2026 | |
| CNTX Context Therapeutics | Reiterated: Buy | $5 | $0.1808 | +2,665.49% | 10 | Nov 11, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 → $8 | $0.9431 | +748.27% | 10 | Nov 10, 2026 | |
| IMNM Immunome | Rated: Buy | $33 → $30 | $18.77 | +59.83% | 17 | Nov 10, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $10 | $0.8387 | +1,092.32% | 24 | Nov 6, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $18 | $6.84 | +163.16% | 18 | Nov 5, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $35 | $15.48 | +126.10% | 12 | Nov 2, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $120 | $78.30 | +53.26% | 37 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $865 → $1,000 | $955.47 | +4.66% | 49 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $71 → $90 | $29.22 | +208.01% | 15 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7738 | +675.39% | 9 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.92 | +180.61% | 9 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $4.13 | +21.07% | 11 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.98 | +176.38% | 5 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.10 | +192.68% | 12 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $6.21 | +399.19% | 29 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $123 | $72.00 | +70.83% | 10 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $127.57 | +9.74% | 4 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.35 | +418.52% | 3 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.6772 | +933.67% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $13.68 | +338.60% | 1 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $14.62 | +228.32% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $7 | $1.58 | +344.44% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $51 | $3.39 | n/a | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $0.7 | - | n/a | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $70 | $1.70 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $167.40 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $17.50 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.3105 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $6.39 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $6.73 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $2.76 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $1.29 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $3.37 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $109 | $1.28 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $60 | $7.76 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.17 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $0.1388 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $9 | $2.04 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $18 | $47.03 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $63.37 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.30 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0003 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $11 | $3.09 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $46.25 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $6.02 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.0005 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $28.83 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.000001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $10.64 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $152.48 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $538.60 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.00 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $1.18 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.413 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $23.93 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $8.36 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $8.18 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.0001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $40.48 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.7261 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $0.906 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $37.27 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $69.00 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $168.08 | n/a | 1 | Jan 27, 2010 |
Crescent Biopharma
Nov 13, 2026
Rated: Buy
Price Target: $35 → $32
Current: $14.15
Upside: +126.15%
Sarepta Therapeutics
Nov 13, 2026
Reiterated: Hold
Price Target: $20
Current: $16.07
Upside: +24.46%
BridgeBio Oncology Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $21 → $15
Current: $2.14
Upside: +600.93%
Context Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $5
Current: $0.1808
Upside: +2,665.49%
Perspective Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $14 → $8
Current: $0.9431
Upside: +748.27%
Immunome
Nov 10, 2026
Rated: Buy
Price Target: $33 → $30
Current: $18.77
Upside: +59.83%
Allogene Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8387
Upside: +1,092.32%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $18
Current: $6.84
Upside: +163.16%
Nurix Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $35
Current: $15.48
Upside: +126.10%
BridgeBio Pharma
Oct 30, 2026
Reiterated: Buy
Price Target: $120
Current: $78.30
Upside: +53.26%
Oct 30, 2026
Reiterated: Buy
Price Target: $865 → $1,000
Current: $955.47
Upside: +4.66%
Oct 29, 2026
Rated: Buy
Price Target: $71 → $90
Current: $29.22
Upside: +208.01%
Oct 26, 2026
Reiterated: Buy
Price Target: $6
Current: $0.7738
Upside: +675.39%
Oct 19, 2026
Reiterated: Buy
Price Target: $11
Current: $3.92
Upside: +180.61%
Oct 19, 2026
Reiterated: Hold
Price Target: $7 → $5
Current: $4.13
Upside: +21.07%
Oct 16, 2026
Reiterated: Buy
Price Target: $11
Current: $3.98
Upside: +176.38%
Oct 16, 2026
Reiterated: Buy
Price Target: $12
Current: $4.10
Upside: +192.68%
Oct 12, 2026
Reiterated: Buy
Price Target: $31
Current: $6.21
Upside: +399.19%
Sep 28, 2026
Reiterated: Buy
Price Target: $101 → $123
Current: $72.00
Upside: +70.83%
Sep 23, 2026
Reiterated: Buy
Price Target: $140
Current: $127.57
Upside: +9.74%
Aug 27, 2026
Reiterated: Buy
Price Target: $7
Current: $1.35
Upside: +418.52%
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.6772
Upside: +933.67%
Aug 12, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $13.68
Upside: +338.60%
Jun 1, 2026
Reiterated: Buy
Price Target: $48
Current: $14.62
Upside: +228.32%
Mar 30, 2026
Reiterated: Hold
Price Target: $5 → $7
Current: $1.58
Upside: +344.44%
Oct 20, 2025
Reiterated: Buy
Price Target: $35 → $51
Current: $3.39
Upside: n/a
Mar 21, 2025
Downgraded: Hold
Price Target: $10 → $0.7
Current: -
Upside: n/a
May 19, 2023
Reiterated: Buy
Price Target: $63 → $70
Current: $1.70
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $167.40
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $17.50
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.3105
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $14 → $19
Current: $6.39
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $6.73
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $2.76
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $1.29
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $3.37
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $39 → $109
Current: $1.28
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $43 → $60
Current: $7.76
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.17
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $0.1388
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $10 → $9
Current: $2.04
Upside: n/a
Jul 29, 2020
Reiterated: Hold
Price Target: $36 → $18
Current: $47.03
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $63.37
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $2.30
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0003
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $6 → $11
Current: $3.09
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $46.25
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $6.02
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.0005
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $28.83
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.000001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $10.64
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $152.48
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $538.60
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $5.00
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $1.18
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $0.413
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $23.93
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $8.36
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $8.18
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.0001
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $12 → $11
Current: $40.48
Upside: n/a
Feb 22, 2016
Reiterated: Buy
Price Target: $15
Current: $0.7261
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $0.906
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $37.27
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $69.00
Upside: n/a
Jan 27, 2010
Reiterated: Buy
Price Target: $29
Current: $168.08
Upside: n/a